James E. Crowe Jr.
Crowe, James E., Jr.
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
Crowe, James E.
VIAF ID: 314911912 (Personal)
Permalink: http://viaf.org/viaf/314911912
Preferred Forms
-
200 _ |
‡a
Crowe
‡b
James E.
-
100 1 _
‡a
Crowe, James E
‡c
Jr
-
100 1 _ ‡a Crowe, James E.
-
100 1 _ ‡a Crowe, James E., Jr.
-
100 1 _
‡a
Crowe, James E.,
‡c
Jr.
-
100 1 _ ‡a Crowe, James E., ‡c Jr.
-
100 1 _
‡a
Crowe, James E.,
‡c
Jr.
-
100 0 _
‡a
James E. Crowe Jr.
4xx's: Alternate Name Forms (6)
Works
| Title | Sources |
|---|---|
| Antibodies for infectious diseases |
|
| Human antibodies that neutralize respiratory droplet transmissible H5N1 influenza viruses |
|
| Plasma deconvolution identifies broadly neutralizing antibodies associated with hepatitis C virus clearance |
|
| Pneumocystis carinii pneumonia in a girl with a midbrain glioma |
|
| The potent and broadly neutralizing human dengue virus-specific monoclonal antibody 1C19 reveals a unique cross-reactive epitope on the bc loop of domain II of the envelope protein |
|
| A potent anti-dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surface |
|
| Potent anti-influenza H7 human monoclonal antibody induces separation of hemagglutinin receptor binding head domains |
|
| Potent Neutralizing Human Monoclonal Antibodies Preferentially Target Mature Dengue Virus Particles: Implication for Novel Strategy for Dengue Vaccine |
|
| Potently neutralizing human antibodies that block SARS-CoV-2 receptor binding and protect animals |
|
| Predicting posttransplantation diabetes mellitus by regulatory T-cell phenotype: implications for metabolic intervention to modulate alloreactivity |
|
| Prevalence of Reovirus‐Specific Antibodies in Young Children in Nashville, Tennessee |
|
| Prevention of Fetal and Early Life Infections Through Maternal–Neonatal Immunization |
|
| Principles of Broad and Potent Antiviral Human Antibodies: Insights for Vaccine Design |
|
| Prior Dengue virus exposure shapes T cell immunity to Zika virus in humans |
|
| Progression of respiratory syncytial virus infection monitored by fluorescent quantum dot probes |
|
| Proof of principle for epitope-focused vaccine design |
|
| Prophylactic and therapeutic testing of Nicotiana-derived RSV-neutralizing human monoclonal antibodies in the cotton rat model |
|
| Prospective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses in adult recipients of hematopoietic stem cell transplants for hematologic malignancies |
|
| Protective antibodies against Eastern equine encephalitis virus bind to epitopes in domains A and B of the E2 glycoprotein |
|
| Pseudovirion particle production by live poxvirus human immunodeficiency virus vaccine vector enhances humoral and cellular immune responses |
|
| Pseudovirion particles bearing native HIV envelope trimers facilitate a novel method for generating human neutralizing monoclonal antibodies against HIV. |
|
| PyIR: a scalable wrapper for processing billions of immunoglobulin and T cell receptor sequences using IgBLAST |
|
| Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein |
|
| Recent advances in the study of human antibody responses to influenza virus using optimized human hybridoma approaches |
|
| Recombinant human respiratory syncytial virus (RSV) monoclonal antibody Fab is effective therapeutically when introduced directly into the lungs of RSV-infected mice |
|
| Recurrent Achromobacter xylosoxidans Bacteremia Associated with Persistent Lymph Node Infection in a Patient with Hyper-Immunoglobulin M Syndrome |
|
| Recurrent Pneumococcal Arthritis as the Presenting Manifestation of X-Linked Agammaglobulinemia |
|
| Redesigned HIV antibodies exhibit enhanced neutralizing potency and breadth |
|
| Reply to Schlapbach et al |
|
| Respiratory syncytial virus assembles into structured filamentous virion particles independently of host cytoskeleton and related proteins |
|
| Respiratory syncytial virus induces host RNA stress granules to facilitate viral replication |
|
| Respiratory syncytial virus nucleoprotein-specific cytotoxic T-cell epitopes in a South African population of diverse HLA types are conserved in circulating field strains |
|
| Respiratory syncytial virus regulates human microRNAs by using mechanisms involving beta interferon and NF-κB. |
|
| Respiratory syncytial virus uses a Vps4-independent budding mechanism controlled by Rab11-FIP2 |
|
| Reversion of somatic mutations of the respiratory syncytial virus-specific human monoclonal antibody Fab19 reveal a direct relationship between association rate and neutralizing potency |
|
| Role of antibody heavy and light chain interface residues in affinity maturation of binding to HIV envelope glycoprotein |
|
| The role of human metapneumovirus in upper respiratory tract infections in children: a 20-year experience |
|
| Role of Non-local Interactions between CDR Loops in Binding Affinity of MR78 Antibody to Marburg Virus Glycoprotein. |
|
| Rotavirus-specific CD5+ B cells in young children exhibit a distinct antibody repertoire compared with CD5- B cells |
|
| Satisfactorily attenuated and protective mutants derived from a partially attenuated cold-passaged respiratory syncytial virus mutant by introduction of additional attenuating mutations during chemical mutagenesis |
|
| Secondary mechanisms of diversification in the human antibody repertoire. |
|
| Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes |
|
| Simultaneous Exposure to Intracellular and Extracellular Photosensitizers for the Treatment of Staphylococcus aureus Infections |
|
| Single molecule-sensitive probes for imaging RNA in live cells |
|
| A Site of Vulnerability on the Influenza Virus Hemagglutinin Head Domain Trimer Interface |
|
| Smallpox Vaccination Does Not Elevate Systemic Levels of Prothrombotic Proteins Associated with Ischemic Cardiac Events |
|
| Specificity for human hemoglobin enhances Staphylococcus aureus infection |
|
| Spleen Tyrosine Kinase (Syk) Mediates IL-1β Induction by Primary Human Monocytes during Antibody-enhanced Dengue Virus Infection |
|
| A stabilized respiratory syncytial virus reverse genetics system amenable to recombination-mediated mutagenesis |
|
| STAT4 deficiency fails to induce lung Th2 or Th17 immunity following primary or secondary respiratory syncytial virus (RSV) challenge but enhances the lung RSV-specific CD8+ T cell immune response to secondary challenge |
|
| Structural basis for norovirus neutralization by an HBGA blocking human IgA antibody |
|
| Structural basis of a potent human monoclonal antibody against Zika virus targeting a quaternary epitope |
|
| Structural Basis of Preexisting Immunity to the 2009 H1N1 Pandemic Influenza Virus |
|
| Structural Basis of Protection against H7N9 Influenza Virus by Human Anti-N9 Neuraminidase Antibodies |
|
| Structural Diversity of Ultralong CDRH3s in Seven Bovine Antibody Heavy Chains |
|
| Structure-function characterization of three human antibodies targeting the vaccinia virus adhesion molecule D8. |
|
| Structure of the human metapneumovirus fusion protein with neutralizing antibody identifies a pneumovirus antigenic site |
|
| Structures of Ebola virus GP and sGP in complex with therapeutic antibodies |
|
| Surfing a genetic association interaction network to identify modulators of antibody response to smallpox vaccine |
|
| Synergistic anti-HCV broadly neutralizing human monoclonal antibodies with independent mechanisms. |
|
| Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection |
|
| Teaching a Clone to Walk, One Step at a Time |
|
| Therapeutic administration of a recombinant human monoclonal antibody reduces the severity of chikungunya virus disease in rhesus macaques |
|
| Therapeutic treatment of Marburg and Ravn virus infection in nonhuman primates with a human monoclonal antibody. |
|
| Therapy with CTLA4-Ig and an antiviral monoclonal antibody controls chikungunya virus arthritis |
|
| Tissue-specific expressed antibody variable gene repertoires |
|
| Tissue-specific regulation of CD8+ T-lymphocyte immunodominance in respiratory syncytial virus infection |
|
| Tissue-specific regulatory T cells: biomarker for acute graft-vs-host disease and survival |
|
| Towards a consensus on datasets and evaluation metrics for developing B-cell epitope prediction tools |
|
| Transcriptional Control of Activation-Induced Cytidine Deaminase and Error-Prone DNA Polymerases Is Functionally Mature in the B Cells of Infants at Birth |
|
| Transforming growth factor beta is a major regulator of human neonatal immune responses following respiratory syncytial virus infection |
|
| The Transmembrane Domain of the Respiratory Syncytial Virus F Protein Is an Orientation-Independent Apical Plasma Membrane Sorting Sequence |
|
| Treating Flu with Skin of Frog. |
|
| Universal flu vaccines: primum non nocere |
|
| Unusual features of vaccinia virus extracellular virion form neutralization resistance revealed in human antibody responses to the smallpox vaccine |
|
| An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccines |
|
| Use of Human Hybridoma Technology To Isolate Human Monoclonal Antibodies |
|
| Using the natural evolution of a rotavirus-specific human monoclonal antibody to predict the complex topography of a viral antigenic site |
|
| Vaccination success rate and reaction profile with diluted and undiluted smallpox vaccine: a randomized controlled trial |
|
| Vaccine-elicited antibody that neutralizes H5N1 influenza and variants binds the receptor site and polymorphic sites |
|
| Venezuelan equine encephalitis virus replicon particles encoding respiratory syncytial virus surface glycoproteins induce protective mucosal responses in mice and cotton rats |
|
| VH1-46 is the dominant immunoglobulin heavy chain gene segment in rotavirus-specific memory B cells expressing the intestinal homing receptor alpha4beta7. |
|
| Viral Pneumonia |
|
| ভূমিকা |
|
